Letter: Adoption of Uniform Nomenclature Is Crucial for Estimating the True Risk of HBV Reactivation in Patients Treated With Direct-Acting Antivirals for Hepatitis C

Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.14653
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley